The Clostridioides Difficile Trial of REC-3964
Study sponsor: Recursion Pharmaceuticals Inc. · RXRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-05-06Actual
Enrollment · participants3Actual
Source updated2025-11-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.